今开:0.0 | 昨收:0.0812 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.1770367E7 |
智通财经APP获悉,美国制药商Clovis Oncology(CLVS.US)上周日在美国特拉华州申请破产保护,原因是该公司的抗癌药销量下滑、且在筹集额外资金方面面临挑战。 数据显示,2022年迄今为止,Clovis Oncology股价暴跌超92%,目前股价为0.2002... 网页链接
智通财经APP获悉,生物制药公司Clovis Oncology (CLVS.US)表示,与安慰剂对照相比,Rubraca作为初始维持治疗药物改善了卵巢癌患者在疾病风险小组的无进展生存时间(PFS)。截至发稿,Clovis Oncology 盘前涨11.30%至1.2800美元,该股盘前... 网页链接
$Clovis肿瘤药物(CLVS)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-22-000797 Act: 34 Size: 3 KB 网页链接
$Clovis肿瘤药物(CLVS)$ 8-K Current report, items 2.03 and 9.01 Accession Number: 0001193125-22-308420 Act: 34 Size: 282 KB 网页链接
$Clovis肿瘤药物(CLVS)$ 8-K Current report, item 3.01 Accession Number: 0001193125-22-303183 Act: 34 Size: 153 KB 网页链接
$Clovis肿瘤药物(CLVS)$ 8-K Current report, items 1.01, 1.03, 2.03, 2.04, 8.01, and 9.01 Accession Number: 0001193125-22-303179 Act: 34 Size: 757 KB 网页链接
$Clovis肿瘤药物(CLVS)$ 8-K Current report, items 2.04 and 8.01 Accession Number: 0001193125-22-297593 Act: 34 Size: 156 KB 网页链接
$Clovis肿瘤药物(CLVS)$ 8-K Current report, item 8.01 Accession Number: 0001193125-22-286772 Act: 34 Size: 146 KB 网页链接
$Clovis肿瘤药物(CLVS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-22-017027 Act: 34 Size: 10 MB 网页链接
$Clovis肿瘤药物(CLVS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034890 Size: 15 KB 网页链接
$Clovis肿瘤药物(CLVS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034892 Size: 15 KB 网页链接
$Clovis肿瘤药物(CLVS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-034896 Size: 21 KB 网页链接